EricMarkHorwitzMDFABS, FASTRO(He/Him)

PubMed

• 352 citations
  Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
  Juanita Crook, Christopher J. O'Callaghan, Graeme Duncan, David P. Dearnaley, Celestia S. Higano
  The New England Journal of Medicine. 2012-08-29
• 273 citations
  Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology
  James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael B. Cohen
  Journal of the National Comprehensive Cancer Network. 2014-05-01
• 509 citations
  Prostate Cancer, Version 1.2016
  James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony V. D'Amico, Brian J. Davis
  Journal of the National Comprehensive Cancer Network. 2016-01-01

Journal Articles

• Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...  
  Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
• Institutional clinical trial accrual volume and survival of patients with head and neck cancer  
  Wuthrick, E.J.; Zhang, Q.; Machtay, M.; Rosenthal, D.I.; Nguyen-Tan, P.F.; Fortin, A.; Silverman, C.L.; Raben, A.; Kim, H.E.; Horwitz, E.M.; Read, N.E.; Harris, J.; Wu..., J Clin Oncol, 1/1/2015
• Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer  
  Martin, J.M.; Handorf, E.A.; Price, R.A.; Cherian, G.; Buyyounouski, M.K.; Chen, D.Y.; Kutikov, A.; Johnson, M.E.; Ma, C. M.; Horwitz, E.M., Med Dosim, 1/1/2015
• Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Tria...  
  Klotz, L, O'Callaghan, C, Ding, K, Toren, P, Dearnaley, D, Higano, CS, Horwitz, E.M., Malone, S, Goldenberg, L, Gospodarowicz, M, Crook, JM, J Clin Oncol, 1/1/2015
• SU-E-T-747: The Use of the EQD2 Formalism and Repair Estimates in the Re-Irradiation Setting and Correlation with Patient Follow-Up Data  
  Price, R., Meyer, J., Horwitz, EM., Ma, C., Med Phys, 1/1/2015
• Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer  
  Wang, L.S., Murphy, C.T., Ruth, K., Zaorsky, N.G., Smaldone, M. C., Sobczak, M.L., Kutikov, A., Viterbo, R., Horwitz, E.M., Cancer, 1/1/2015
• Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center  
  Martin, J.M., Li, T., Johnson, M.E., Murphy, C.T., Howald, A.G., Smaldone, M.C., Kutikov, A., Chen, D.Y., Viterbo, R., Greenberg, R.E., Uzzo, R.G., Horwitz, E.M., J Natl Compr Canc Netw, 1/1/2015
• Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled  
  Huang, K.T., Stoyanova, R., Walker, G., Sandler, K., Studenski, M.T., Dogan, N., Al-Saleem, T., Buyyounouski, M.K., Horwitz, E.M., Pollack, A., Radiother Oncol, 1/1/2015
• Does family history of prostate cancer affect outcomes following radiotherapy?  
  Bagshaw, H.; Ruth, K.; Horwitz, E.M.; Chen, D. Y.; Buyyounouski, M. K., Radiother. Oncol., 1/1/2014
• Reply to MJ Brenner et al and IR Vogelius et al  
  Pollack, A.; Walker, G.; Horwitz, E.M.; Price, R.; Feigenberg, S.; Konski, A. A.; Stoyanova, R.; Movsas, B.; Greenberg, R. E.; Uzzo, R. G.; Ma, C.; Buyyounouski, M. K., J. Clin. Oncol., 1/1/2014
• Prostate cancer, version 22014  
  Mohler, J. L.; Kantoff, P. W.; Armstrong, A. J.; Bahnson, R. R.; Cohen, M.; D'Amico, A. V.; Eastham, J. A.; Enke, C. ; A.; Farrington, T. A.; Higano, C. S.; Horwitz, E..., J Natl Compr Canc Netw, 1/1/2014
• Medicare physician payment data: Is this transparency?  
  Horwitz, E.M. and Weinberg, D.S., Ann. Int. Med., 1/1/2014
• Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with mode...  
  Murphy, C.T.; Heller, S.; Ruth, K.; Buyyounouski, M.K.; Weinberg, D.; Uzzo, R.G.; Plimack, E.; Kutikov, A.; Chen, D.Y.; Horwitz, E.M., Practical Radiation Oncology, 1/1/2014
• Is it necessary to perform week three dosimetric analysis in low-dose rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment  
  Shaikh, T.; Zaorsky, N. G.; Ruth, K.; Chen, D.Y.; Greenberg, R.E.; Li, J.; Crawford, K.; Horwitz, E.M., Brachytherapy, 1/1/2014
• Reduction of prostate intrafractional motion from shortening the treatment time  
  Li, J.; Lin, M.-H.; Buyyounouski, M.K.; Horwitz, E.M.; Ma, C.-M., Phys. Med. Biol., 1/1/2013
• A Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy and the Need for Age-Based Risk-Adapted Dose Constraints  
  Ahmed, A.A.; Egleston, B.; Alcantara, P.; Li, L.N.; Pollack, A.; Horwitz, E.M.; Buyyounouski, M.K., International Journal of Radiation Oncology Biology Physics, 1/1/2013
• In reply to Cheung  
  Turaka, A.; Buyyounouski, M.K.; Horwitz, E.M.; Movsas, B., Oncol Biol Phys, 1/1/2013
• Seminal Vesicle Target Delineation for Intermediate-Risk Prostate Cancer IMRT  
  Johnson, M. E.; Ruth, K.; Buyyounouski, M. K.; Horwitz, E.M., Pract. Radiat. Oncol., 1/1/2013
• ABS brachytherapy consensus guidelines  
  Horwitz EM, Brachytherapy, 1/1/2012
• American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy  
  Davis BJ, Horwitz EM, Lee WR, Crook, J. M.; Stock, R. G.; Merrick, G. S.; Butler, W. M.; Grimm, P. D.; Stone, N. N.; Potters, L.; Zietman, A. L.; Zelefsky, M. J., Brachytherapy, 1/1/2012
• Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy  
  Lubbe, W.; Cohen, R.; Sharma, N.; Ruth, K.; Peters, R.; Li, J.; Buyyounouski, M.K.; Kutikov, A.; Chen, D.Y.; Uzzo, R.G.; Horwitz, E.M., Brachytherapy, 1/1/2012
• A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update  
  Buyyounouski, MK.; Davis, B.J.; Prestidge, B.R.; Shanahan, T.G.; Stock, R.G.; Grimm, P.D.; Demanes, D.J.; Zaider, M.; Horwitz, E.M., Brachytherapy, 1/1/2012
• Intermittent androgen suppression for rising PSA level after radiotherapy  
  Crook, J.M.; O'Callaghan, C.J.; Duncan, G.; Dearnaley, D.P.; Higano, C.S.; Horwitz, E.M.; Frymire, E.; Malone, S.; Chin, J.; Nabid, A.; Warde, P.; Corbett, T.; Angyalf..., New England Journal of Medicine, 1/1/2012
• Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy  
  Zaorsky, N.G.; Buyyounouski, M.K.; Li T.; Horwitz, E.M., International Journal of Radiation Oncology Biology Physics, 1/1/2012
• Prostate Bed Motion during Intensity-Modulated Radiotherapy Treatment  
  Klayton, T.; Price, R.; Buyyounouski, M.K.; Sobczak, M.; Greenberg, R.E.; Li, J.; Keller, L.; Sopka, D.; Kutikov, A.; Horwitz, E.M., International Journal of Radiation Oncology Biology Physics, 1/1/2012
• Join now to see all

Books/Book Chapters

• Image-Guided Radiation Therapy: A Clinical Perspective 
  Chapter: MR-guided target delineation in a patient with prostate cancer. 
  Buyyounouski, M.K. and Horwitz, E.M.Editors: Mundt, A.J. and Roeske, J..People's Medical Publishing House, Shelton, CT2011
• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Recurrence following Radiotherapy: Definitions, Prognosis and Management. 
  Horwitz, E.M.Editors: Vogelzang, N.J.; Scardino, P.T.; Zelefsky, M.J.; and Linehan, W.M. with Rini, B.I.; Bochner, B.H. and Sheinfeld, J..Lippincott, Williams, & Wilkins, Philadelphia, PAEdition 4th,2010
• Handbook of Radiation Oncol-Basic Principles and Clinical Protocols 
  Chapter: Prostate Cancer. 
  Page 565 - 582Buyyounouski, M.K.; Horwitz, E.M.; Pollack, A.Editors: Haffty, B. and Wilson, L.D..Jones and Bartlett Publishers, Sudbury, MA2009
• Prostate Cancer: Principles and Practices of Image-guided Radiation Therapy 
  Chapter: IGRT in prostate cancer: focus on BAT ultrasound. 
  Page 103 - 112Silverman, J.S. and Horwitz, E.M.Editors: Valicenti, R.K., Dicker, A.P., and Jaffray, D.A..Informa Healthcare USA, Inc., NY, NY2008
• Prostate Cancer-Principles and Practice 
  Chapter: Initial management of high risk early stage prostate cancer: Radiation. 
  Page 855 - 863Horwitz, E.M.; Feigenberg, S.J.; Pollack, A.Editors: Kirby, R.S., Partin, A.W., Feneley, M., and Parsons, J.K..Taylor & Francis, Boca Raton2006
• Intensity Modulated Radiation Therapy: A Clinical Perspective 
  Chapter: Intact prostate cancer: Overview 
  Page 436 - 448Pollack, A.; Price, R.A.; Dong, L.; Feigenberg, S.J.; Horwitz, E.M.Editors: AJ Mundt and JC Roeske.BC Decker, Inc, ON, Canada2005
• Intensity Modulated Radiation Therapy: A Clinical Perspective 
  Chapter: Intact prostate cancer: Case Study. 
  Page 459 - 463Price, R.A.; Horwitz, E.M.; Feigenberg, S.J.; Pollack, A.Editors: AJ Mundt and JC Roeske.BC Decker, Inc, ON, Canada2005
• Cancer Management: A Multidisciplinary Approach 
  Chapter: Head and neck tumors. 
  Page 37 - 78Ridge, J.A.; Glisson, B.S.; Horwitz, E.M.; Meyers, M.; and Fein, D.A.Editors: Pazdur, R., Coia, L.R., Hoskins, W.J., and Wagman, L.D..PRR, Huntington, NY2002
• Advanced Therapy Of Prostatic Disease 
  Chapter: T3-T4NxM0: The case for radiotherapy. 
  Page 284 - 290Horwitz, E.M. and Hanks, G.E.Editors: Resnick, M.I. and Thompson, I.M..B.C. Decker, Inc., Hamilton1999
• Comprehensive Textbook Of Genitourinary Oncology 
  Chapter: Hormonal therapy combined with radiation or surgery in the treatment of locally advanced non-metastatic prostate cancer. 
  Horwitz, E.M. and Hanks, G.E.Editors: Vogelzang, N.J., Scardino, P.T., Shipley, W.U., and Coffey, D.S..Lippincott, Williams, & Wilkins, Baltimore1999
• Current Clinical Oncology: Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done 
  Chapter: Tumor resistance to apoptosis. 
  Uzzo, R.G.; Cairns, P.; Dulin, N.; Horwitz, E.M.; Pollack, A.; Kolenko, V.Editors: Finke, J.H. and Bukowski, R.M..Humana Press Inc., Totowa, NJ
• Join now to see all

Abstracts/Posters

• The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience.
  Horwitz, E.M.; Sharma, N.K.; Ruth, K.J.; Silverman, J.S.; Buyyounouski, M.K.; Chen, D.Y.T.; Greenberg, R.E.; Uzzo, R.G., 52nd Annual Meeting of the American Society of Radiation Oncology, San Diego, CA, 1/31/2010
• The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience.
  Horwitz, E.M.; Sharma, N.K.; Ruth, K.J.; Silverman, J.S.; Buyyounouski, M.K.; Chen, D.Y.T.; Greenberg, R.E.; Uzzo, R.G., International Journal of Radiation Oncology Biology and Physics, 1/1/2010
• Undetectable Post-Treatment PSA Following 3DCRT or IMRT Alone For Patients with Low or Intermediate Risk Prostate Cancer Is an Independent Predictor of Biochemical and...
  Horwitz, E.M.; Ruth, K.; Sharma, N.K.; Chen, D.Y.T.; Buyyounouski, M.K.; Uzzo, R.G., 51st Annual Meeting of the American Society of Radiation Oncology, Chicago, IL, 1/1/2009
• Undetectable Post-Treatment PSA Following 3DCRT or IMRT Alone For Patients with Low or Intermediate Risk Prostate Cancer Is an Independent Predictor of Biochemical and...
  Horwitz, E.M.; Ruth, K.J.; Sharma, N.K.; Chen, D.Y.T.; Buyyounouski, M.K.; Uzzo, R.G., International Journal of Radiation Oncology Biology and Physics, 1/1/2009
• PSA Doubling Time Predicts for the Development of Distant Metastases for Patients Who Fail 3DCRT Or IMRT ssing The Phoenix Definition.
  Horwitz, E.M.; Ruth, K.; Uzzo, R.G.; Buyyounouski, M.K.; Wong, Y.-N.; Chen, D.Y.T.; Pollack, A., 50th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 1/21/2008
• PSA Doubling Time Predicts For The Development Of Distant Metastases For Patients Who Fail 3DCRT or IMRT Using The Phoenix Definition.
  Horwitz, E.M.; Ruth, K.; Uzzo, R.G.; Buyyounouski, M.K.; Wong, Y.-N.; Chen, D.Y.T.; Pollack, A., International Journal of Radiation Oncology Biology and Physics, 1/1/2008
• The Phoenix Definition of Biochemical Failure Correlates With Clinical Failure For Men Treated With Adjuvant And Salvage Post-Prostatectomy Radiation: Results of the M...
  Horwitz, E.M.; Hanlon, A.L.; Pisansky, T.M.; Sandler, H.M.; Kuban, D.A.; Catton, C.; Michalski, J.M.; Stephenson, A.; Pollack, A.; and the Post-Prostatectomy Radiation..., 49th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Los Angeles, CA, 1/28/2007
• The Phoenix definition of biochemical failure correlates with clinical failure for men treated with adjuvant and salvage post-prostatectomy radiation: Results of the m...
  Horwitz, E.M.; Hanlon, A.L.; Pisansky, T.M.; Sandler, H.M.; Kuban, D.A.; Catton, C.; Michalski, J.M.; Stephenson, A.; Pollack, A. and the Post-Prostatectomy Radiation ..., International Journal of Radiation Oncology Biology and Physics, 1/1/2007
• The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significan...
  Horwitz, E.M.; Levy, L.B.; Martinez, A.A.; Potters, L.; Beyer, D.C.; Blasko, J.C.; Sandler, H.M.; Buskirk, S.J.; Zietman, A.L.; Kuban, D.A., 48th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 1/4/2006
• The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significan...
  Horwitz, E.M.; Levy, L.B.; Martinez, A.A.; Potters, L.; Beyer, D.C.; Blasko, J.C.; Sandler, H.M.; Buskirk, S.J.; Zietman, A.L.; Kuban, D.A., International Journal of Radiation Oncology Biology and Physics, 1/1/2006
• Phase II Study Of Paclitaxel & Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer ...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., 47th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Denver, CO, 1/16/2005
• Treatment with TNF-a and TPEN decreases NF-kB activity and induces apoptosis in PC-3 cells.
  Crispen PL.; Golovine C.; Makhov P.; Pollack A.; Horwitz E.M.; Greenberg RE.; Uzzo R.; Kolenko V, Proceedings of the Society of Urologic Oncology, 1/1/2005
• Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Car...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., Proceedings of the American Society of Clinical Oncology, 1/1/2005
• Phase II Study Of Paclitaxel & Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer ...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., International Journal of Radiation Oncology Biology and Physics, 1/1/2005
• Phase II Study Of Paclitaxel, Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer O...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., 6th International Head and Neck Meeting, Washington, DC, 1/8/2004
• The Biochemical And Clinical Significance Of The Post-Treatment PSA Bounce For Prostate Cancer Patients Treated With External Beam Radiation Therapy Alone: A Multi-Ins...
  Horwitz, E.M.; Levy, L.B.; Thames, H.D.; Kuban, D.A.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., 46th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, GA, 1/3/2004
• Phase II Study Of Paclitaxel, Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer O...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., Proceedings of the 6th International Head and Neck Meeting, 1/1/2004
• The Biochemical And Clinical Significance Of The Post-Treatment PSA Bounce For Prostate Cancer Patients Treated With External Beam Radiation Therapy Alone: A Multi-Ins...
  Horwitz, E.M.; Levy, L.B.; Thames, H.D.; Kuban, D.A.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., International Journal of Radiation Oncology Biology and Physics, 1/1/2004
• Using MRI-simulation to define radiation dose to the penile bulb and corporal bodies for prostate cancer patients treated with intensity modulated radiation therapy or...
  Horwitz, E.M.; Buyyounouski, M.K.; Uzzo, R.G.; Price, R.A.; McNeeley, S.W.; Aziz, D.; Hanlon, A.L.; Milestone, B.N.; Pollack, A., 85th Annual Meeting of the American Radium Society, Houston, TX, 1/26/2003
• Definitions Of Biochemical Failure That Best Predict Clinical Failure In Prostate Cancer Patients Treated With External Beam Radiation Alone-A Multi-Institutional Pool...
  Horwitz, E.M.; Thames, H.D.; Kuban, D.A.; Levy, L.B.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., 45th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Salt Lake City, UT, 1/19/2003
• Definitions Of Biochemical Failure That Best Predict Clinical Failure In Prostate Cancer Patients Treated With External Beam Radiation Alone-A Multi-Institutional Pool...
  Horwitz, E.M.; Thames, H.D.; Kuban, D.A.; Levy, L.B.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., International Journal of Radiation Oncology Biology and Physics, 1/1/2003
• A new 3D non-uniform edema resolution model for prostate following permanent seed implant based upon serial radiography and MRI simulation.
  Horwitz, E.M.; Mitra, R.K.; Mah, D.; Hanlon, A.L.; Uzzo, R.G.; Pollack, A., 23rd Annual Meeting of the American Brachytherapy Society, Orlando, FL, 1/22/2002
• Does backdating change outcome when the ASTRO definition of biochemical control is used in patients with clinically localized prostate cancer treated with 3D conformal...
  Horwitz, E.M.; Uzzo, R.G.; Hanlon, A.L.; Greenberg, R.E.; Hanks, G.E.; Pollack, A., 44th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, New Orleans, LA, 1/6/2002
• A new 3D non-uniform edema resolution model for prostate following permanent seed implant based upon serial radiography and MRI simulation.
  Horwitz, E.M.; Mitra, R.K.; Uzzo, R.G.; Mah, D.; Hanlon, A.L.; Pollack, A., Proceedings of the American Brachytherapy Society, 1/1/2002
• Prostate cancer dose response to conformal radiotherapy.
  Pollack, A.; Hanlon, A.L.; Horwitz, E.M.; Hanks, G.E., Journal of Urology, 1/1/2002
• Join now to see all

Lectures

• Biochemical and Clinical Outcomes of Patients with Non-Metastatic Prostate Cancer Treated with Definitive Radiation Therapy or Surgery. 
  Atlanta, GA - 1/23/2015
• Newest Trends in Radiation Oncology for Prostate Cancer. 
  Royal Hospital, Muscat, Oman - 1/16/2014
• Invited lecture, "Education Session 305: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  San Francisco, CA - 1/16/2014
• Principles of Radiation Therapy: Radiotherapy & Proton Therapy for Urologic Malignancy. 
  Philadelphia, PA - 1/6/2014
• Invited lecture, "Education Session 308: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  Atlanta, GA - 1/24/2013
• Radiation treatment options for non-metastatic prostate cancer: From IMRT to brachytherapy. 
  Xi'an, China - 1/21/2013
• Brachytherapy for Prostate Cancer: State of the Art in 2013. 
  Philadelphia, PA - 1/4/2013
• Plenary Session: The Next 20 Years: An Update on Prostate Cancer Treatment and Trends. 
  Philadelphia, PA - 1/26/2011
• The ABS approach to quality assurance. 
  Houston, TX - 1/3/2011
• Moderator: "Plenary Session." 
  1/29/2010
• "Presidential Address: Quality Assurance-Education, Regulation and the Role of the ABS in the Practice of Brachytherapy in 2010." 
  Atlanta, GA - 1/28/2010
• RT Options and Outcomes for localized intermediate risk disease. 
  Sydney, Australia - 1/18/2010
• High Risk Localized disease: Should radiotherapy be first line? 
  Sydney, Australia - 1/18/2010
• High Risk Localized Disease. 
  Sydney, Australia - 1/18/2010
• Localized Disease (Low and Intermediate Risk). 
  Sydney, Australia - 1/18/2010
• Is There a Preferred Treatment for High Risk Prostate Carcinoma? The Case for IMRT and Androgen Deprivation Therapy. 
  New York, NY - 1/15/2010
• Invited lecture, "Education Session 205: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  San Diego, CA - 1/1/2010
• Presentation: "High Risk Prostate Cancer: IMRT +/-Androgen Deprivation Therapy." 
  Toronto, Ontario, Canada - 1/31/2009
• State of the Art Treatment of Prostate Cancer. 
  Philadelphia, PA - 1/22/2009
• Adjuvant Post-Operative Radiotherapy. 
  Bethesda, MD - 1/13/2009
• "Recent Advances In External Beam Radiotherapy" 
  Bethesda, MD - 1/13/2009
• Androgen Deprivation Therapy And Radiation: Who Gets It and For How Long? 
  Bethesda, MD - 1/13/2009
• Invited lecture, "Education Session 202: Radiotherapy for Favorable Risk Prostate Cancer: A Review of all the Options." 
  Chicago, IL - 1/2/2009
• Invited lecture, "Education Session 206: Radiotherapy for Favorable Risk Prostate Cancer: A Review of all the Options." 
  Boston, MA - 1/22/2008
• Plenary Session: State of the Art Brachytherapy in the Treatment of Prostate Cancer. 
  Philadelphia, PA - 1/22/2008
• Join now to see all